ESR1 Mutated Metastatic Breast Cancer Diagnostics Market By Test Type (NGS Based and PCR Based), By Sample Type (Plasma and Tissue), By End-user (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, and Cancer Research Institutes), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 165121
- Number of Pages: 221
- Format:
-
keyboard_arrow_up
-
-
- Sysmex Corporation
- RainSure Scientific Co., Ltd.
- NeoGenomics Laboratories, Inc.
- Illumina, Inc.
- Guardant Health, Inc.
- GENCURIX Inc.
- CUSABIO Technology LLC
- Cayman Chemical Company
- ASURAGEN, Inc.
- APIS Assay Technologies Ltd.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible